ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $568,681 | -69.4% | 27,288 | -64.9% | 0.02% | -68.6% |
| Q2 2023 | $1,860,652 | -49.8% | 77,689 | -60.5% | 0.07% | -54.5% |
| Q1 2023 | $3,705,846 | +1631.7% | 196,910 | +1403.1% | 0.15% | +1825.0% |
| Q3 2022 | $214,000 | -89.2% | 13,100 | -90.7% | 0.01% | -90.7% |
| Q2 2022 | $1,984,000 | +23.7% | 140,769 | +112.5% | 0.09% | +24.6% |
| Q1 2022 | $1,604,000 | -16.8% | 66,244 | -16.2% | 0.07% | -62.9% |
| Q2 2021 | $1,928,000 | – | 79,060 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |